These changes are considered beneficial in this population, as hyperandrogenism contributes to PCOS symptomatology and metabolic complications
doi:10.3389/fendo.2022.945609 35
Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) Semaglutide (Ozempic, Rybelsus, Wegovy) Tirzepatide (Mounjaro, Zepbound)
Retatrutide has a higher overall adverse event burden (6-10% discontinuation), partly because of the unique dysesthesia side effect at higher doses
Once degradation has occurred, refrigeration does not reverse it
For type 2 diabetes patients with a prior history of cannabis use disorder, the findings were consistent with those observed in the obesity group, showing a reduced risk of recurrence though the difference was not statistically significant